Hyppigheden (95% konfidensinterval) af lymfomer var 1. 0 (0, 2, 3, 8) pr.
(0.2, 3.8) per 1000 patient-years among Trudexa-treated patients and 1.0 (0.1, 7.3) per 1000 patient- years among control patients.